TD Cowen Forecasts Strong Price Appreciation for Keurig Dr Pepper (NASDAQ:KDP) Stock

Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its price objective lifted by equities research analysts at TD Cowen from $33.00 to $35.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen‘s price objective suggests a potential downside of 5.16% from the company’s current price.

A number of other equities research analysts have also recently issued reports on the company. BNP Paribas Exane boosted their price objective on Keurig Dr Pepper from $28.00 to $29.00 and gave the company a “neutral” rating in a research note on Monday, August 10th. Morgan Stanley lifted their target price on shares of Keurig Dr Pepper from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Keurig Dr Pepper in a report on Friday, August 7th. JPMorgan Chase & Co. boosted their target price on shares of Keurig Dr Pepper from $38.00 to $39.00 and gave the company an “overweight” rating in a report on Thursday, October 22nd. Finally, Argus restated a “buy” rating and set a $36.00 target price on shares of Keurig Dr Pepper in a research report on Tuesday, September 15th. Ten investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $36.65.

Check Out Our Latest Analysis on KDP

Keurig Dr Pepper Stock Performance

Shares of Keurig Dr Pepper stock traded up $2.17 on Wednesday, reaching $36.91. 14,434,071 shares of the company traded hands, compared to its average volume of 12,233,594. The company has a 50 day moving average of $32.58 and a 200 day moving average of $30.07. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.48 and a quick ratio of 0.28. Keurig Dr Pepper has a 52 week low of $24.88 and a 52 week high of $37.31. The firm has a market capitalization of $50.22 billion, a PE ratio of 37.23, a PEG ratio of 1.75 and a beta of 0.35.

Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.62 by $0.04. Keurig Dr Pepper had a return on equity of 10.80% and a net margin of 7.10%. The business had revenue of $7.34 billion for the quarter, compared to the consensus estimate of $7.33 billion. During the same quarter in the prior year, the business earned $0.54 earnings per share. Keurig Dr Pepper’s revenue for the quarter was up 70.6% on a year-over-year basis. Equities analysts forecast that Keurig Dr Pepper will post 2.30 earnings per share for the current year.

Insider Activity at Keurig Dr Pepper

In other news, Director Aaron Alt bought 7,862 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The shares were acquired at an average price of $31.83 per share, with a total value of $250,247.46. Following the acquisition, the director owned 7,862 shares of the company’s stock, valued at approximately $250,247.46. The trade was a ? increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $32.55, for a total transaction of $390,600.00. Following the completion of the sale, the insider owned 84,171 shares in the company, valued at $2,739,766.05. This represents a 12.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.34% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Keurig Dr Pepper

A number of institutional investors have recently added to or reduced their stakes in KDP. AlphaCore Capital LLC boosted its position in shares of Keurig Dr Pepper by 58.8% during the 3rd quarter. AlphaCore Capital LLC now owns 20,196 shares of the company’s stock valued at $613,000 after acquiring an additional 7,476 shares during the last quarter. Retirement Systems of Alabama increased its position in Keurig Dr Pepper by 664.0% in the third quarter. Retirement Systems of Alabama now owns 2,183,609 shares of the company’s stock worth $66,251,000 after purchasing an additional 1,897,787 shares during the last quarter. Fulcrum Asset Management LLP raised its stake in Keurig Dr Pepper by 1,691.7% during the third quarter. Fulcrum Asset Management LLP now owns 3,225 shares of the company’s stock valued at $100,000 after purchasing an additional 3,045 shares in the last quarter. Brighton Jones LLC raised its stake in Keurig Dr Pepper by 4.4% during the third quarter. Brighton Jones LLC now owns 38,525 shares of the company’s stock valued at $1,169,000 after purchasing an additional 1,634 shares in the last quarter. Finally, Candriam S.C.A. lifted its position in Keurig Dr Pepper by 1.5% during the third quarter. Candriam S.C.A. now owns 152,232 shares of the company’s stock valued at $4,636,000 after purchasing an additional 2,316 shares during the last quarter. 93.99% of the stock is currently owned by institutional investors.

Keurig Dr Pepper News Roundup

Here are the key news stories impacting Keurig Dr Pepper this week:

  • Positive Sentiment: KDP reported third-quarter adjusted EPS of $0.66, above analyst estimates, while net sales reached $7.34 billion, up about 70% year over year, largely reflecting the JDE Peet’s acquisition. The company reaffirmed its full-year 2026 guidance. KDP Q3 results and guidance
  • Positive Sentiment: Growth was particularly strong in beverages: energy-drink market share topped 10%, and U.S. refreshment beverage sales increased. The company’s energy portfolio and brands such as Dr Pepper Zero Sugar helped support momentum. Long-term investor takeaways
  • Positive Sentiment: Morgan Stanley raised its price target to $40 and maintained an Overweight rating; Piper Sandler also lifted its target, to $41. The higher targets signal continued analyst optimism. Morgan Stanley ratings Piper Sandler price target
  • Neutral Sentiment: KDP is preparing to separate its beverage and coffee businesses in early 2027. The potential restructuring may sharpen investor focus on each business, though execution and market conditions remain factors. 2026 sales outlook and planned separation
  • Negative Sentiment: The coffee business faces pressure as price-sensitive shoppers trade down to cheaper options. Management lowered its legacy EPS growth outlook, making beverage growth and JDE Peet’s contribution more important to the overall story. Coffee profit and consumer trading-down report

About Keurig Dr Pepper

(Get Free Report)

Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.

The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.

Featured Stories

Analyst Recommendations for Keurig Dr Pepper (NASDAQ:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.